resveratrol has been researched along with Cognition Disorders in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (12.90) | 29.6817 |
| 2010's | 27 (87.10) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, X; Bo, S; Chen, X; Wang, X; Xie, Y; Zhang, Q; Zhang, T | 1 |
| Chen, Y; Liang, ZM; Peng, L; Sheng, SY; Shi, GW; Shi, YS; Wang, F; Wang, YP; Zhang, XM | 1 |
| Dong, QX; Liu, RT; Qiu, M; Sun, X; Sun, XY; Yu, XL; Zhang, LF; Zhu, J | 1 |
| Chopra, K; Tiwari, V | 2 |
| Ji, MH; Li, XM; Wang, XM; Yang, JJ; Zhou, MT; Zhou, ZQ | 1 |
| Chen, C; Cheng, XS; Du, LL; Jiang, X; Kong, FL; Li, XH; Ma, ZW; Wang, JZ; Xie, JZ; Zhou, XW | 1 |
| Gu, J; Jiang, H; Liu, D; Wang, J; Wang, X; Wang, Z; Xian, X; Xie, K; Zhang, Q | 1 |
| Anastácio, JR; Castro, CC; Dalmaz, C; Ferreira, DC; Krolow, R; Netto, CA; Noschang, C; Pagnussat, A; Sanches, EF | 1 |
| Dew, TP; Haskell, CF; Kennedy, DO; Reay, JL; Wightman, EL; Williamson, G | 1 |
| Bigford, GE; Del Rossi, G | 1 |
| Miller, MG; Poulose, SM; Shukitt-Hale, B; Thangthaeng, N | 1 |
| Bi, W; Dubner, L; Ferruzzi, M; Freire, D; Ho, L; Mazzola, P; Pasinetti, GM; Wang, J; Yemul, S; Zhao, W | 1 |
| Álvarez, A; Arteaga, O; Hilario, E; Montalvo, H; Revuelta, M; Urigüen, L | 1 |
| Evans, HM; Howe, PR; Wong, RH | 1 |
| Howe, PR; Nealon, RS; Scholey, A; Wong, RH | 1 |
| Howe, PR; Raederstorff, D; Wong, RH | 1 |
| An, R; Dang, H; Geng, T; Liang, X; Liu, Y; Ren, G; Tian, X; Yin, L | 1 |
| Di Giacomo, S; Mazzanti, G | 1 |
| Tian, Z; Wang, J; Wang, Y; Xu, M; Zhang, M; Zhou, Y | 1 |
| Ahn, J; Aisen, PS; Hebron, M; Huang, X; Moussa, C; Rissman, RA; Turner, RS | 1 |
| Cheng, J; Han, S; Qin, L; Rui, Y; Wan, Z; Xu, J; Yin, X; Yuan, L | 1 |
| Cheng, V; Fisher, DR; Joseph, JA; Rimando, AM; Shukitt-Hale, B | 1 |
| Kim, J; Lee, HJ; Lee, KW | 1 |
| Bhattacharya, SK; Gupta, LK; Gupta, R; Mediratta, PK | 1 |
| He, W; Liu, GS; Yang, B; Zhang, ZS | 1 |
| Baydas, G; Demir, N; Etem, A; Etem, EO; Koz, S; Koz, ST; Kuloğlu, T; Ozercan, HI; Yuce, H | 1 |
| Madhyastha, S; Rao, GM; Sahu, SS | 1 |
| Gupta, YK; Sharma, M | 1 |
| Kumar, A; Naidu, PS; Padi, SS; Seghal, N | 1 |
| Baykara, B; Erbil, G; Sönmez, A; Sönmez, U; Tekmen, I | 1 |
4 review(s) available for resveratrol and Cognition Disorders
| Article | Year |
|---|---|
Supplemental substances derived from foods as adjunctive therapeutic agents for treatment of neurodegenerative diseases and disorders.
Topics: Acetylcarnitine; Alzheimer Disease; Brain; Brain Injuries; Cinnamates; Cognition Disorders; Curcumin; Depsides; Diet; Dietary Supplements; Fatty Acids, Omega-3; Humans; Neurodegenerative Diseases; Oxidative Stress; Polyphenols; Resveratrol; Rosmarinic Acid; Stilbenes | 2014 |
Effects of pterostilbene and resveratrol on brain and behavior.
Topics: Aging; Animals; Antioxidants; Blood-Brain Barrier; Brain; Cognition Disorders; Humans; Neurodegenerative Diseases; Resveratrol; Social Behavior Disorders; Stilbenes; Treatment Outcome | 2015 |
Curcumin and Resveratrol in the Management of Cognitive Disorders: What is the Clinical Evidence?
Topics: Animals; Clinical Trials as Topic; Cognition Disorders; Curcumin; Female; Humans; Male; Resveratrol; Stilbenes | 2016 |
Naturally occurring phytochemicals for the prevention of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Catechin; Cognition Disorders; Curcumin; Dietary Supplements; Humans; Oxidative Stress; Phytotherapy; Plant Extracts; Resveratrol; Stilbenes | 2010 |
5 trial(s) available for resveratrol and Cognition Disorders
| Article | Year |
|---|---|
Effects of resveratrol alone or in combination with piperine on cerebral blood flow parameters and cognitive performance in human subjects: a randomised, double-blind, placebo-controlled, cross-over investigation.
Topics: Adult; Alkaloids; Benzodioxoles; Cerebrovascular Circulation; Cognition; Cognition Disorders; Cohort Studies; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Female; Frontal Lobe; Humans; Intestinal Absorption; Male; Nootropic Agents; Pilot Projects; Piperidines; Polyunsaturated Alkamides; Resveratrol; Spectroscopy, Near-Infrared; Stilbenes; Task Performance and Analysis; Young Adult | 2014 |
Clinical Evaluation of Effects of Chronic Resveratrol Supplementation on Cerebrovascular Function, Cognition, Mood, Physical Function and General Well-Being in Postmenopausal Women-Rationale and Study Design.
Topics: Affect; Aged; Aged, 80 and over; Cerebrovascular Circulation; Clinical Protocols; Cognition; Cognition Disorders; Dementia; Dietary Supplements; Double-Blind Method; Female; Health Status; Humans; Mental Health; Middle Aged; Neuropsychological Tests; New South Wales; Phytoestrogens; Postmenopause; Regional Blood Flow; Research Design; Resveratrol; Risk Factors; Stilbenes; Time Factors; Treatment Outcome; Ultrasonography, Doppler, Transcranial | 2016 |
Low dose resveratrol improves cerebrovascular function in type 2 diabetes mellitus.
Topics: Aged; Blood Flow Velocity; Cerebrovascular Circulation; Cerebrovascular Disorders; Cognition; Cognition Disorders; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Middle Cerebral Artery; Posterior Cerebral Artery; Resveratrol; Stilbenes; Time Factors; Treatment Outcome; Ultrasonography, Doppler, Transcranial; Vasodilation; Victoria | 2016 |
Acute Resveratrol Consumption Improves Neurovascular Coupling Capacity in Adults with Type 2 Diabetes Mellitus.
Topics: Adult; Aged; Aged, 80 and over; Attention; Blood Flow Velocity; Cerebral Arteries; Cerebrovascular Circulation; Cognition; Cognition Disorders; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Male; Middle Aged; Neurovascular Coupling; New South Wales; Resveratrol; Stilbenes; Time Factors; Trail Making Test; Treatment Outcome; Ultrasonography, Doppler, Transcranial; Vasodilation | 2016 |
Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer's disease.
Topics: Activities of Daily Living; Adaptive Immunity; Alzheimer Disease; Amyloid beta-Peptides; Anti-Inflammatory Agents, Non-Steroidal; Chemokine CCL5; Cognition Disorders; Cytokines; Double-Blind Method; Encephalitis; Female; Fibroblast Growth Factor 2; Follow-Up Studies; Humans; Male; Matrix Metalloproteinase 9; Mental Status Schedule; Peptide Fragments; Resveratrol; Stilbenes; tau Proteins | 2017 |
22 other study(ies) available for resveratrol and Cognition Disorders
| Article | Year |
|---|---|
Resveratrol reversed chronic restraint stress-induced impaired cognitive function in rats.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Brain-Derived Neurotrophic Factor; Cognition Disorders; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Hippocampus; Male; Maze Learning; Rats; Rats, Wistar; Resveratrol; Stilbenes; Stress, Physiological | 2017 |
Resveratrol improves cognition and decreases amyloid plaque formation in Tg6799 mice.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Cognition Disorders; Disease Models, Animal; Male; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Transgenic; Plaque, Amyloid; Presenilin-1; Resveratrol | 2019 |
Resveratrol Rescues Tau-Induced Cognitive Deficits and Neuropathology in a Mouse Model of Tauopathy.
Topics: Animals; Brain; Cell Line, Tumor; Cognition Disorders; Disease Models, Animal; Humans; Inflammation; Male; Mice, Transgenic; Neuroprotective Agents; Nootropic Agents; Phosphorylation; Resveratrol; Synapses; tau Proteins; Tauopathies | 2019 |
Resveratrol abrogates alcohol-induced cognitive deficits by attenuating oxidative-nitrosative stress and inflammatory cascade in the adult rat brain.
Topics: Acetylcholinesterase; Animals; Antioxidants; Anxiety; Catalase; Central Nervous System Depressants; Cognition Disorders; Encephalitis; Ethanol; Glutathione; Interleukin-1beta; Lipid Peroxidation; Male; Maze Learning; Memory; Motor Activity; NF-kappa B; Nitrites; Oxidative Stress; Rats; Rats, Wistar; Reactive Nitrogen Species; Resveratrol; Stilbenes; Stress, Physiological; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2013 |
Resveratrol pretreatment attenuates the isoflurane-induced cognitive impairment through its anti-inflammation and -apoptosis actions in aged mice.
Topics: Age Factors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Apoptosis Regulatory Proteins; Carrier Proteins; Cognition Disorders; Freezing Reaction, Cataleptic; Hippocampus; Interleukin-1beta; Isoflurane; Male; Mice; Mice, Inbred C57BL; Neurons; NLR Family, Pyrin Domain-Containing 3 Protein; Resveratrol; Sirtuin 1; Stilbenes; Tumor Necrosis Factor-alpha | 2014 |
Activation of sirtuin 1 attenuates cerebral ventricular streptozotocin-induced tau hyperphosphorylation and cognitive injuries in rat hippocampi.
Topics: Aging; Animals; Antioxidants; Blotting, Western; Cerebral Ventricles; Cognition; Cognition Disorders; Disease Models, Animal; Fluorometry; Hippocampus; Injections, Intraperitoneal; Male; MAP Kinase Signaling System; Phosphorylation; Rabbits; Rats; Rats, Sprague-Dawley; Resveratrol; Sirtuin 1; Stilbenes; Streptozocin; tau Proteins; Vasodilator Agents | 2014 |
Resveratrol prevents impaired cognition induced by chronic unpredictable mild stress in rats.
Topics: Animals; Brain-Derived Neurotrophic Factor; Cognition Disorders; Corticosterone; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Hippocampus; Male; Maze Learning; Neuroprotective Agents; Phosphorylation; Prefrontal Cortex; Rats; Recognition, Psychology; Resveratrol; Stilbenes; Stress, Psychological | 2014 |
Resveratrol treatment has neuroprotective effects and prevents cognitive impairment after chronic cerebral hypoperfusion.
Topics: Animals; Brain Ischemia; Cell Count; Cognition Disorders; Hippocampus; Male; Maze Learning; Memory, Short-Term; Nerve Growth Factor; Neurons; Neuroprotective Agents; Neuropsychological Tests; Random Allocation; Rats, Wistar; Resveratrol; Spatial Memory; Stilbenes | 2014 |
Novel application of brain-targeting polyphenol compounds in sleep deprivation-induced cognitive dysfunction.
Topics: Animals; Brain; Cognition Disorders; Dose-Response Relationship, Drug; Drug Delivery Systems; Grape Seed Extract; Mice; Mice, Inbred C57BL; Polyphenols; Rats; Rats, Sprague-Dawley; Resveratrol; Sleep Deprivation; Stilbenes | 2015 |
Pretreatment with Resveratrol Prevents Neuronal Injury and Cognitive Deficits Induced by Perinatal Hypoxia-Ischemia in Rats.
Topics: Animals; Animals, Newborn; Astrocytes; Behavior, Animal; Brain; Brain Injuries; Cognition Disorders; Disease Models, Animal; Female; Hypoxia-Ischemia, Brain; Male; Membrane Potential, Mitochondrial; Mitochondria; Myelin Basic Protein; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; Stilbenes | 2015 |
Resveratrol limits diabetes-associated cognitive decline in rats by preventing oxidative stress and inflammation and modulating hippocampal structural synaptic plasticity.
Topics: Animals; Antioxidants; Blood Glucose; Cognition; Cognition Disorders; Cognitive Dysfunction; Diabetes Complications; Diabetes Mellitus, Experimental; Hippocampus; Inflammation; Male; Maze Learning; Memory; Neuronal Plasticity; Oxidative Stress; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Superoxide Dismutase; Synapses | 2016 |
Resveratrol Improves Cognitive Impairment by Regulating Apoptosis and Synaptic Plasticity in Streptozotocin-Induced Diabetic Rats.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Blood Glucose; Blotting, Western; Brain-Derived Neurotrophic Factor; Caspase 3; Cognition Disorders; Diabetes Mellitus, Experimental; Disease Models, Animal; Male; Maze Learning; Neuronal Plasticity; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Resveratrol; Stilbenes; Streptozocin; Up-Regulation | 2016 |
Vitamin D Combined with Resveratrol Prevents Cognitive Decline in SAMP8 Mice.
Topics: Aging; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Antioxidants; Aspartic Acid Endopeptidases; Brain; Cathepsin B; Cognition; Cognition Disorders; Disease Models, Animal; Drug Therapy, Combination; Glycogen Synthase Kinase 3; In Situ Nick-End Labeling; Mice; Nerve Tissue Proteins; Peptide Fragments; Resveratrol; Signal Transduction; Stilbenes; tau Proteins; Vitamin D | 2017 |
Cellular and behavioral effects of stilbene resveratrol analogues: implications for reducing the deleterious effects of aging.
Topics: Aging; Animals; Calcium; Chlorocebus aethiops; Cognition Disorders; COS Cells; Diet; Dopamine; Male; Oxidative Stress; Rats; Rats, Inbred F344; Receptor, Muscarinic M1; Resveratrol; Stilbenes; Transfection | 2008 |
Resveratrol prevents alcohol-induced cognitive deficits and brain damage by blocking inflammatory signaling and cell death cascade in neonatal rat brain.
Topics: Acetylcholinesterase; Animals; Animals, Newborn; Antioxidants; Brain Damage, Chronic; Caspase 3; Cell Death; Central Nervous System Depressants; Cognition Disorders; Ethanol; Inflammation; Lipid Peroxidation; Male; Maze Learning; Memory; Nerve Degeneration; Neuroprotective Agents; NF-kappa B; Rats; Rats, Wistar; Resveratrol; Signal Transduction; Stilbenes; Superoxide Dismutase | 2011 |
Effect of resveratrol on scopolamine-induced cognitive impairment in mice.
Topics: Animals; Avoidance Learning; Behavior, Animal; Cognition Disorders; Injections, Intraperitoneal; Maze Learning; Memory Disorders; Mice; Motor Activity; Muscarinic Antagonists; Neuroprotective Agents; Reaction Time; Resveratrol; Scopolamine; Stilbenes; Treatment Outcome | 2012 |
Resveratrol attenuates oxidative damage and ameliorates cognitive impairment in the brain of senescence-accelerated mice.
Topics: Aging; Animals; Antioxidants; Brain; Cognition Disorders; DNA, Mitochondrial; Fallopia japonica; Gene Deletion; Glutathione Peroxidase; Male; Malondialdehyde; Maze Learning; Memory; Mice; Oxidative Stress; Resveratrol; RNA, Messenger; Stilbenes; Superoxide Dismutase | 2012 |
Effects of resveratrol on blood homocysteine level, on homocysteine induced oxidative stress, apoptosis and cognitive dysfunctions in rats.
Topics: Animals; Antioxidants; Aorta; Apoptosis; Cognition Disorders; DNA Fragmentation; Homocysteine; In Situ Nick-End Labeling; Lipid Peroxidation; Male; Maze Learning; Oxidative Stress; Polymerase Chain Reaction; Rats; Rats, Wistar; Resveratrol; Stilbenes | 2012 |
Neuroprotective effect of resveratrol against prenatal stress induced cognitive impairment and possible involvement of Na(+), K(+)-ATPase activity.
Topics: Animals; Antioxidants; Brain; Cognition Disorders; Disease Models, Animal; Female; Male; Maze Learning; Neuroprotective Agents; Pregnancy; Prenatal Exposure Delayed Effects; Rats, Wistar; Restraint, Physical; Resveratrol; Sodium-Potassium-Exchanging ATPase; Stilbenes; Stress, Psychological | 2013 |
Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats.
Topics: Animals; Antioxidants; Behavior, Animal; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Injections, Intraventricular; Learning; Male; Oxidative Stress; Rats; Rats, Wistar; Resveratrol; Stilbenes; Streptozocin | 2002 |
Neuroprotective effects of resveratrol against intracerebroventricular colchicine-induced cognitive impairment and oxidative stress in rats.
Topics: Acetylcholinesterase; Administration, Oral; Animals; Antioxidants; Behavior, Animal; Brain; Cognition Disorders; Colchicine; Glutathione; Injections, Intraventricular; Lipid Peroxidation; Male; Malondialdehyde; Maze Learning; Memory Disorders; Neuroprotective Agents; Nitrites; Oxidative Stress; Rats; Rats, Wistar; Resveratrol; Space Perception; Stilbenes; Tubulin Modulators | 2007 |
Neuroprotective effects of resveratrol against traumatic brain injury in immature rats.
Topics: Animals; Animals, Newborn; Antioxidants; Anxiety; Brain Injuries; Cell Death; Cognition Disorders; Hippocampus; Injections, Intraperitoneal; Memory; Memory Disorders; Nerve Degeneration; Neuroprotective Agents; Rats; Rats, Wistar; Resveratrol; Stilbenes; Treatment Outcome | 2007 |